Is Sinovac's EV71 Vaccine on the Verge of CFDA Approval? $SVA

In late September, I met with Chinese biopharma Sinovac Biotech (ticker: SVA). At the time, management said it expected CFDA approval for its novel EV71 vaccine by early 2016. The same was said on its November earnings call. So did the stock rally this week in anticipation?

EXCLUSIVE: IDI CEO on the “Transformational Transaction”, Dr. Frost, & the Path to Billions

In a “transformational transaction” earlier this week, IDI (ticker: IDI) (Analysis) acquired digital marketing and customer acquisition firm Fluent.

IDI - Building An Extraordinary Business $IDI

This is the second in a series of substantive articles on IDI (ticker: IDI) from Jeff Geygan and his team at Global Value Research Company. I'm publishing with permission:

Fund Manager Remains Bullish on IDI $IDI

In his latest quarterly investor letter, Threshold Capital's Peter Delgado discusses his latest thoughts on IDI (ticker: IDI) (published with permission):

Exclusive Interview: Chinese biopharma Sinovac (SVA) Makes a Compelling Case

Last week I met with management of Chinese small-cap Sinovac (ticker: SVA) while they were in New York for the Morgan Stanley Healthcare Conference. We spoke for almost an hour. Here’s the conversation in full (lightly edited):

The Bull Case for IDI ( $IDI )

Jay Thompson of SkyTides has written an exhaustive rebuttal to the recent short attack against IDI Inc (IDI). I encourage you to read it. As for IDI's future, Jay concludes with the following:

IDI - A Potent Legacy Advantage $IDI

Below is an excellent new piece on IDI Inc (IDI) from Jeff Geygan and his team at Global Value Research Company. They understand the IDI story as well as anyone. I'm publishing this with permission. Stay tuned for the next in their series:

Crisis IR in the Age of Social Media - IDI

Last week an anonymous blog post caused a mass exodus in shares of IDI Inc. (IDI).

Exclusive Interview: IDI Management Shreds Anonymous Blog Post, Buys Stock $IDI

Short sellers play an important role in any public equity market.

Questions for GigaMedia (GIGM) ???

I'm scheduled to meet with Taiwan-based online gaming and e-commerce company GigaMedia (ticker: GIGM) this week.

Exclusive Interview: IDI Inc. (IDI) Chairman is Bullish on the New Direction

As you will see below, Mike Brauser, the new Chairman of IDI Inc (IDI) (formerly Tiger Media) has enjoyed tremendous professional success.

He also happens to be a business partner of billionaire Dr. Phillip Frost.

Is There a Better Investor Relations Model in the Age of Social Media?

If you’re an investor you demand many things.

In his Latest Annual Letter, Warren Buffett Talks Investor Relations

Every year, famed investor Warren Buffett writes an annual letter to Berkshire shareholders.

10 New Ways Companies are Sharing their Earnings Call Key Messages

Once their earnings calls end, public company executives typically call it a day.

20 New Strategies Companies are Using to Engage Investors

Traditional investor relations practices alone are no longer enough.